Galaxy Therapeutics lands CE mark for Seal embolisation system
Galaxy Therapeutics lands CE mark for Seal embolisation system NeuroNews International
August 2026
FDA approves Charlotte company’s drug for cardiac disorder affecting thousands of patients
FDA approves Charlotte company's drug for cardiac disorder affecting thousands of patients The Business Journals
Tip Sheet: Experts discover fibromyalgia risk factors; FDA approves new breast cancer drug — and public health genome platform expands to new phase
Tip Sheet: Experts discover fibromyalgia risk factors; FDA approves new breast cancer drug — and public health genome platform expands…
FDA Clears Rituximab Biosimilar, Expanding Options for B-Cell Malignancies
FDA Clears Rituximab Biosimilar, Expanding Options for B-Cell Malignancies Targeted Oncology